Related Experiment Video
Updated: May 30, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Longitudinal study of bone mineral density in children with idiopathic hypercalciuria
Maria Goretti Moreira Guimarães Penido1, Marcelo de Sousa Tavares, Mariana Campos Linhares
1Pediatric Nephrology Unit, Clinics Hospital, School of Medicine, Federal University of Minas Gerais, Avenida Alfredo Balena, 190, Santa Efigenia, Belo Horizonte, 30130100 Minas Gerais, Brazil. mariagorettipenido@yahoo.com.br
Insights
Idiopathic hypercalciuria in children can lower bone mineral density (BMD). Treatment with potassium citrate and thiazides significantly improved BMD z-scores, suggesting a beneficial effect on bone health.
Area of Science:
- Pediatric Nephrology
- Endocrinology
- Bone Metabolism
Background:
- Idiopathic hypercalciuria (IH) in children is associated with reduced bone mineral density (BMD).
- Optimal treatment strategies for pediatric IH and its impact on long-term bone health remain unclear.
- Early intervention may be crucial for preventing potential bone complications in adulthood.
Purpose of the Study:
- To evaluate the effect of potassium citrate and thiazide treatment on lumbar-spine BMD z-scores in pediatric patients with IH.
- To assess changes in bone mineral density before and after a course of medical therapy.
- To investigate the potential of treatment to mitigate negative impacts on bone health.
Main Methods:
- Retrospective cohort study of 80 pediatric patients diagnosed with idiopathic hypercalciuria.
- Dual-emission X-ray absorptiometry (DXA) used for bone scanning and densitometry.
- Statistical analysis using t-tests and Mann-Whitney U tests to compare pre- and post-treatment BMD z-scores.
Main Results:
- A significant improvement in lumbar-spine BMD z-score was observed, increasing from -0.763 ± 0.954 to -0.537 ± 0.898 (p < 0.0001).
- Median calcium excretion decreased significantly from 5.0 to 2.6 mg/kg/24 h after treatment.
- The study included 43 boys and 37 girls, followed for a median of 6.0 years.
Conclusions:
- Treatment with potassium citrate and thiazides appears to be beneficial for improving bone mineral density z-scores in children and adolescents with idiopathic hypercalciuria.
- These findings suggest a positive impact of the treatment regimen on bone health.
- Further controlled studies are warranted to confirm these results due to the absence of a control group in this historical cohort.
Abstract:
Children with idiopathic hypercalciuria (IH) may have a reduced bone mineral density (BMD), which could impact on bone health in adulthood. There is currently no strong evidence for a preferred treatment of such children. The aim of our study was to evaluate the BMD z-score before and after treating children and adolescents with IH with potassium citrate and thiazides. The study consisted of a historical cohort of 80 pediatric patients who were evaluated between October 1989 and November 2010. Bone scanning and densitometry measurements were made with dual-emission X-ray absorptiometry. Lumbar-spine BMD (g/cm(2)) and BMD z-score were evaluated before and after treatment. The t test and Mann-Whitney U test were used for statistical analysis. Forty-three boys and 37 girls were followed for a median time of 6.0 years. Median calcium excretion before and after treatment was 5.0 and 2.6 mg/kg/24 h, respectively. The BMD z-score changed significantly from -0.763 ± 0.954 (mean ± SD) to -0.537 ± 0.898 (p < 0.0001) before and after treatment, respectively. The BMD z-score of the patients improved with treatment, suggesting a beneficial effect and potential need for treatment. However, the lack of a control group points to the need for future studies to corroborate this outcome.
Related Concept Videos
Urinary Tract Calculi I: Introduction
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Skeleton and Calcium Homeostasis
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi III: Medical Management
